A Trial to Test the Safety and Efficacy of TEV-53408 in Participants With Vitiligo
Public ClinicalTrials.gov record NCT06625177. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b, Open-Label Trial to Assess Safety and Exploratory Efficacy of TEV-53408 in Participants With Vitiligo
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the trial is to evaluate the safety of TEV-53408 when given as an under the skin injection to adults with vitiligo. Vitiligo is a condition where patches of skin lose color (pigment) and turn white.
Study identification
- NCT ID
- NCT06625177
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 66 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 11, 2024 (Actual)
- Primary completion
- Apr 26, 2028 (Estimated)
- Completion
- Jan 31, 2029 (Estimated)
- Last update posted
- Oct 29, 2026
2024 – 2029
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Scottsdale Clinical Research | Scottsdale | Arizona | 85260 | Terminated |
| Burke Pharmaceutical Research | Hot Springs | Arkansas | 71913 | Recruiting |
| Center for Dermatology Clinical Research, Inc. | Fremont | California | 94538 | Recruiting |
| University of CA Irvine | Irvine | California | 92617 | Active, not recruiting |
| Pasadena Clinical Trials | Pasadena | California | 91101 | Active, not recruiting |
| Watson Therapeutics Inc. (WTI), USA | Miramar | Florida | 33025 | Recruiting |
| MetroMed Clinical Trials | Chicago | Illinois | 60614 | Active, not recruiting |
| DS Research of Kentucky | Louisville | Kentucky | 40421 | Recruiting |
| Hamzavi Dermatology | Canton | Michigan | 48187 | Recruiting |
| Oregon Dermatology and Research Center | Portland | Oregon | 97210 | Recruiting |
| Dermatology Treatment & Research Center | Dallas | Texas | 75230 | Recruiting |
| Center for Clinical Studies, LTD. LLP | Webster | Texas | 77598 | Active, not recruiting |
| Jordan Valley Dermatology | South Jordan | Utah | 84095 | Active, not recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06625177, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 29, 2026 · Synced Nov 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06625177 live on ClinicalTrials.gov.